Abramowitz MC - Search Results

1

Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique.

Algohary A, Zacharaki EI, Breto AL, Alhusseini M, Wallaengen V, Xu IR, Gaston SM, Punnen S, Castillo P, Pattany PM, Kryvenko ON, Spieler B, Abramowitz MC, Pra AD, Ford JC, Pollack A, Stoyanova R. Algohary A, et al. Among authors: abramowitz mc. NMR Biomed. 2024 Mar;37(3):e5069. doi: 10.1002/nbm.5069. Epub 2023 Nov 21. NMR Biomed. 2024. PMID: 37990759

2

The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer.

Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horwitz EM. Abramowitz MC, et al. Cancer. 2008 Jan 1;112(1):55-60. doi: 10.1002/cncr.23139. Cancer. 2008. PMID: 17968996 Free article.

3

Postprostatectomy radiation therapy for prostate cancer.

Abramowitz MC, Pollack A. Abramowitz MC, et al. Semin Radiat Oncol. 2008 Jan;18(1):15-22. doi: 10.1016/j.semradonc.2007.09.003. Semin Radiat Oncol. 2008. PMID: 18082584 Review.

4

Hypofractionated radiotherapy for prostate cancer: has the time come?

Abramowitz MC, Pollack A. Abramowitz MC, et al. Oncology (Williston Park). 2012 Jun;26(6):519, 522. Oncology (Williston Park). 2012. PMID: 22870534 Free article. No abstract available.

5

Weighing the Addition of Androgen Suppression Therapy to Radiotherapy Dose Escalation for Intermediate-Risk Prostate Cancer.

Pollack A, Abramowitz MC. Pollack A, et al. Among authors: abramowitz mc. J Clin Oncol. 2016 May 20;34(15):1715-7. doi: 10.1200/JCO.2015.66.2320. Epub 2016 Mar 14. J Clin Oncol. 2016. PMID: 26976421 No abstract available.

6

Feasibility and Initial Dosimetric Findings for a Randomized Trial Using Dose-Painted Multiparametric Magnetic Resonance Imaging-Defined Targets in Prostate Cancer.

Bossart EL, Stoyanova R, Sandler K, Studenski M, Orman A, Abramowitz M, Pollack A. Bossart EL, et al. Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):827-34. doi: 10.1016/j.ijrobp.2016.01.052. Epub 2016 Feb 4. Int J Radiat Oncol Biol Phys. 2016. PMID: 27020109 Clinical Trial.

7

Quantification of the margin required for treating intraprostatic lesions.

Studenski MT, Valenciaga Y, Abramowitz MC, Stoyanova R, Bossart E, Dogan N, Pollack A. Studenski MT, et al. Among authors: abramowitz mc. J Appl Clin Med Phys. 2016 May 8;17(3):304-312. doi: 10.1120/jacmp.v17i3.6089. J Appl Clin Med Phys. 2016. PMID: 27167286 Free PMC article.

8

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies.

Stoyanova R, Pollack A, Takhar M, Lynne C, Parra N, Lam LL, Alshalalfa M, Buerki C, Castillo R, Jorda M, Ashab HA, Kryvenko ON, Punnen S, Parekh DJ, Abramowitz MC, Gillies RJ, Davicioni E, Erho N, Ishkanian A. Stoyanova R, et al. Among authors: abramowitz mc. Oncotarget. 2016 Aug 16;7(33):53362-53376. doi: 10.18632/oncotarget.10523. Oncotarget. 2016. PMID: 27438142 Free PMC article.

9

Prostate cancer: Moderate hypofractionated radiotherapy - not yet a standard of care.

Pollack A, Abramowitz M. Pollack A, et al. Nat Rev Clin Oncol. 2016 Nov;13(11):655-656. doi: 10.1038/nrclinonc.2016.147. Epub 2016 Sep 20. Nat Rev Clin Oncol. 2016. PMID: 27644320 No abstract available.

10

Dynamic contrast-enhanced MRI for automatic detection of foci of residual or recurrent disease after prostatectomy.

Parra NA, Orman A, Padgett K, Casillas V, Punnen S, Abramowitz M, Pollack A, Stoyanova R. Parra NA, et al. Strahlenther Onkol. 2017 Jan;193(1):13-21. doi: 10.1007/s00066-016-1055-z. Epub 2016 Oct 19. Strahlenther Onkol. 2017. PMID: 27761612 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page